| 翻訳と辞書 |
| Gregory Katz ： ウィキペディア英語版 |
Grégory Katz
Grégory Katz-Bénichou (1971) is a French academic. Katz is currently professor at ESSEC Business School (Paris-Singapore), chaired professor of the ESSEC Chair of Therapeutic Innovation,〔www.essec-therapeutic-innovation.com〕 and co-director of the ESSEC Institute of Health Economics & Management. He also heads the , which promotes research in cell therapy and supports altruistic donations of umbilical cord blood stem cells. He is also Chairman of the Board of GlaxoSmithKline Vaccines’ Global Innovation Fund (IBe+).
== Positions ==
Gregory Katz holds an MBA (1997), a doctorate in philosophy (2000) and a doctorate in pharmacy (1999). Elie Wiesel,〔(【引用サイトリンク】title=Elie Wiesel )〕 Nobel Peace Prize laureate〔(【引用サイトリンク】title=Elie Wiesel - Biographical )〕 and professor at Boston University,〔 mentored his doctorate in philosophy and was a member of his thesis jury at the Université de Paris-Sorbonne.〔(【引用サイトリンク】title=Site officiel de l'Université Paris-Sorbonne (Paris IV) )〕 In 2002, Katz published le ''Chiffre de la vie: réconcilier la génétique et l’humanisme''〔(【引用サイトリンク】title=Le chiffre de la vie )〕'' ''(310 p. Editions du Seuil〔(【引用サイトリンク】title=Le Chiffre de la vie )〕'').'' In 2003, he became a permanent faculty member at ESSEC Business School (Paris-Singapore). In 2004, he was appointed chaired professor of the ESSEC Chair of Therapeutic Innovation, which he created that same year. As visiting professor at INSEAD in 2004-2005 on the Singapore campus, he taught business ethics alongside Henri-Claude de Bettignies〔(【引用サイトリンク】title=Henri-Claude de Bettignies – Faculty & Research – INSEAD )〕 at the Asian Center for Comparative Management. In 2006, Katz was a visiting professor at Bocconi University (Milan)〔(【引用サイトリンク】title=SDA Bocconi School of Management )〕 at the Center for Research on Health Care and Social Management. In 2009 he was named co-director of the ESSEC Institute of Health Economics & Management.〔http://www45.essec.edu/professorsCV/showCV.do?keyUrl=gregory-katz〕 From 2011 to 2013, he was Academic Director of the Executive Master Strategy & Management of Health Industries at ESSEC Executive Education.
Gregory Katz is regularly solicited by health authorities for his expertise on bioethics and on the industrial development of healthcare innovations. He was consulted by the French Senate,〔http://www.senat.fr/rap/r08-079/r08-0791.pdf〕 the Conseil d’Etat,〔http://www.ladocumentationfrancaise.fr/var/storage/rapports-publics/094000288/0000.pdf〕 the European Parliament (''European Group on Ethics in Science and New Technologies'') and UNESCO (''Human Variome Project)''〔(【引用サイトリンク】title=5th Biennial Meeting of the Human Variome Project )〕''.'' He also advises public and private organizations (research institutes, patient associations, hospitals, drug and medical device corporations, insurance companies, and service providers). He has been a member of the first expert group of the French Institutional Review Board (CPP IDF3) since 2012.〔(【引用サイトリンク】title=Composition et missions des CPP )〕 Between 2009 and 2011, he was administrator of the European School of Surgery. From 2004 to 2009, Gregory Katz worked alongside Eliane Gluckman as vice-president of the association Eurocord,〔(【引用サイトリンク】title=Registre Eurocord )〕 an international platform for clinical research on cord blood stem cell transplantation. Eurocord analyzes clinical data from more than 500 transplant centers in 56 countries around the world. In 2010, Eurocord became part of the French ,〔http://www.agence-biomedecine.fr/article/528〕 which now heads its operations. Since 2012, Katz has also been Chairman of the Board of GlaxoSmithKline Vaccines’ (IBe+) Global Innovation Fund.〔http://www.gsk.com/products/our-vaccines.html〕 The fund is dedicated to supporting intrapreneurial projects that deliver value to patients, caregivers and the company.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Grégory Katz」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|